TrialAntimicrobial agents and chemotherapy2006

Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APV.

Mary B Wire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.